Truvestments Capital’s UiPath PATH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$173K Sell
15,928
-298
-2% -$3.18K 0.03% 343
2026
Q1
$180K Buy
16,226
+16,225
+1,622,500% +$207K 0.03% 323
2025
Q4
$23 Hold
1
– – ﹤0.01% 1014
2025
Q3
$19 Hold
1
– – ﹤0.01% 1025
2025
Q2
$18 Buy
+1
New +$12 ﹤0.01% 959
2022
Q3
– Sell
-100
Closed -$2K – 650
2022
Q2
$2K Buy
+100
New +$1.87K ﹤0.01% 569
2022
Q1
– Sell
-100
Closed -$4K – 432
2021
Q4
$4K Buy
+100
New +$4.93K ﹤0.01% 509

Other funds holding PATH

Truvestments Capital's PATH Position: Q2 2026 in Review

Truvestments Capital reduced its UiPath (PATH) stake by 1.8% in Q2 2026, selling an estimated $3.18K and leaving 15,928 shares worth $173K. The position accounts for 0.03% of the portfolio, ranked #343.

Truvestments Capital first reported a position in PATH in Q4 2021 and has held it in 7 quarters since. The position peaked at $180K in Q1 2026. 529 funds tracked by Wall St. Rank hold PATH as of Q2 2026.

  • Truvestments Capital held 15,928 shares of UiPath worth $173K as of Q2 2026.
  • Truvestments Capital sold 298 UiPath shares in Q2 2026, an estimated $3.18K.
  • UiPath made up 0.03% of Truvestments Capital's portfolio in Q2 2026, its #343 holding.
  • Truvestments Capital first reported a position in UiPath in Q4 2021 and has held it in 7 quarters since.
  • Truvestments Capital's UiPath position peaked at $180K in Q1 2026.
  • 529 funds tracked by Wall St. Rank held UiPath as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.